• US: +1 9176726599
  • Login

Peri-implantitis Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

Format: PDF | Pages: 317 | Report ID: MRS1128


Report Description

The global Peri-implantitis market size is estimated at USD 801.7 million in 2020, expanding at a CAGR 10.8% from 2021-2027 to reach 1,600.7 Million USD in 2027.

Market Dynamics

The peri-implantitis market is expected to witness substantial growth over the forecast period. The rising usage of dental implants for prosthetic rehabilitation is expected to drive the worldwide peri-implantitis market during the forecast period. Growing public knowledge about oral hygiene has resulted in an increase in dental visits, which is expected to boost the demand for peri-implantitis. Furthermore, the aging population is likely to play a significant influence in driving up demand for peri-implantitis treatment. Increased smoking rates and tobacco use cause a variety of oral disorders, which is expected to further increase demand for peri-implantitis treatment. Furthermore, technological advancements have resulted in several dental methods such as dental grafting, which are expected to present lucrative opportunities for market players in the peri-implantitis market.

 Furthermore, rising demand for anti-aging treatments and procedures such as wrinkles, age spots, and other procedures is expected to fuel the market growth during the forecast period, owing to the growing elderly population. Furthermore, advanced microdermabrasion devices are likely to expand in popularity among consumers, which would boost market expansion during the forecast period.

Regional Insights

The Europe market is estimated to dominate the global market. Europe dominated the peri-implantitis market owing to the presence of the growing patient population with periodontal conditions. Moreover, technological advancements and growing awareness about dental implants and associated disease among the population is expected to further drive the market growth. In addition, favorable government initiatives, and the availability of developed health care facilities in the region is expected to further propel the growth of market.

Segment Insights

The Peri-implantitis market is fragmented into type and end-user segments. Based on the type, the surgical segment is anticipated to dominate the market. By end-user, dental clinics centers segment is expected to hold the majority of the market share.

Competitive Insights

The Peri-implantitis market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic merger & acquisition, partnership, and new product launches to remain competent in the market. For example, in 2019, OraCare launched Implant Post-Op Care System, to help prevent peri-implantitis.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses market size and forecast of Peri-implantitis by type, region, end-use. In addition, this report introduces the market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

  • Pfizer Inc.
  • Cadila Pharmaceuticals
  • R N. Laboratories
  • Triveni Chemicals
  • Basic Pharma Life Science
  • Prachi Pharmaceuticals
  • Healthy Life Pharma
  • Geistlich Pharma
  • Dawood & Tanner

Type Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Surgical
    • Bone Regeneration
    • Open Flap Debridement
    • Implantoplasty
  • Non-surgical
    • Mechanical Debridement
    • Laser Debridement
    • Antibiotics
    • Others

End User Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Hospitals
  • Dental Clinics

Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The global Peri-implantitis market size is estimated at USD 801.7 million in 2020, expanding at a CAGR 10.8% from 2021-2027 to reach 1,600.7 Million USD in 2027.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global Peri-implantitis market size is expanding at a CAGR 10.8% from 2021-2027 to reach 1,600.7 Million USD in 2027.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The Peri-implantitis market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic merger & acquisition, partnership, and new product launches to remain competent in the market. For example, in 2019, OraCare launched Implant Post-Op Care System, to help prevent peri-implantitis.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.